- Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act
-
Policy Forum | published 25 Apr 2024 PLOS Medicine
- Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
-
Research Article | published 05 Apr 2011 PLOS Medicine
- Off-Label Promotion, On-Target Sales
-
Policy Forum | published 28 Oct 2008 PLOS Medicine
- Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
-
Research Article | published 23 Sep 2008 PLOS Medicine
- XDR-TB in South Africa: Revised Definition
-
Correspondence | published 24 Apr 2007 PLOS Medicine
- Following the Script: How Drug Reps Make Friends and Influence Doctors
-
Policy Forum | published 24 Apr 2007 PLOS Medicine
- Evident Exception in Clinical Practice Not Sufficient to Break Traditional Hypothesis
-
Correspondence | published 28 Feb 2006 PLOS Medicine
- The “PharmFree” Campaign: Educating Medical Students about Industry Influence
-
Student Forum | published 31 Jan 2006 PLOS Medicine
- Learning How Drug Companies Promote Medicines in Nepal
-
Student Forum | published 30 Aug 2005 PLOS Medicine
- The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
-
Policy Forum | published 14 Mar 2005 PLOS Medicine
Results per page
